ACTCD Insider Trading Activity and SEC Form 4 Filings
ACTCD insider trading summary
No open-market insider purchases or sales of Advanced Cell Technology, Inc. (ACTCD) have been reported on SEC Form 4 in the past 12 months.
Latest ACTCD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 10, 2014 | Robert Lanza | Chief Scientific Officer | Sell | $63K (5,000 @ $12.50) |
| Sep 10, 2014 | Robert Lanza | Chief Scientific Officer | Sell | $49K (3,930 @ $12.57) |
| Sep 8, 2014 | Robert Lanza | Chief Scientific Officer | Sell | $50K (5,000 @ $10.00) |
| Sep 8, 2014 | Robert Lanza | Chief Scientific Officer | Sell | $101K (10,000 @ $10.07) |
| Sep 3, 2014 | Robert Lanza | Chief Scientific Officer | Sell | $90K (10,000 @ $9.00) |
| Sep 2, 2014 | Robert Lanza | Chief Scientific Officer | Sell | $81K (10,000 @ $8.12) |
| Sep 2, 2014 | Robert Lanza | Chief Scientific Officer | Sell | $45K (5,000 @ $9.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.